The meaning of the word “metastatic” is rapid transition from one point to another. It is usually used with those types of diseases that have a nature of spreading to various parts of body. Metastatic is generally related with malignancy which is nothing but a medical term for cancer. Thus, metastatic malignant melanoma is nothing but an advanced stage of cancer.

Lung cancer, even when reached the metastatic stage might not show any symptoms when it is diagnosed. These types of cancer is usually identified when a chest X-ray is performed incidentally for another reason. The cancer is said to have reached the metastatic once it starts spreading into different parts of the body.

Chronic Myelogenous Leukemia is the cancer of the white blood cells. This happens when there is an increased development of myeloid cells in the bone marrow, and the pile of these cells occurs in the blood. The chronic myelogenous leukemia is a chronic cancer on the clonal bone marrow, and it is a stem cell disorder where the accumulation of mature neutrophils, eosinophils, and basophils.

Pleural mesothelioma is caused due to exposure to asbestos. It is characterized by chest pain or pleurisy, shortness of breath or dyspnea, fever, lower back pain, swelling of face and limbs, dry, sometimes painful, coughing, coughing up blood, fluid buildup in the lungs, otherwise called pleural effusion, tissue lumps in the chest, and unexplained weight loss.

Mesothelioma might take quite a long time to develop, and the symptoms of the disease may not appear until cancer gets progressed to later stages. While, the early signs of mesothelioma can be easily mistaken for the common, as well as daily ailments. As a result, even the early symptoms are frequently ignored, dismissed, or misdiagnosed.

Immunotherapy tends to give an all-new beginning to the patient and stands head-to-head when compared with standard chemotherapy and the immunotherapy drug nivolumab, Clinical trial research has found that people with squamous non-small cell lung cancer who were treated with nivolumab have lived 3.2 months on an average more than those who were treated with chemotherapy.